OLC | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

4,407 results for “OLC”

Trials

View all 2075 →

Repeatability in Measurements of Two ssOCT and One OLCR Biometer

50 participants · First posted Feb 5, 2020

A Phase lb/ll, Open Label, Single Arm Study With Olinvacimab and Capecitabine in mCRC Patients (OLCAP)

First posted Feb 12, 2021

JPRN-C000000085

Randomized, comparative clinical study of cisplatin and docetaxel combination chemotherapy and mitomycin, vindesine and cisplatin (MVP) combination chemotherapy with concurrent thoracic radiation therapy for locally advanced unresectable non-small-cell lung cancer (OLCSG0007)

200 participants

Drugs

View all 569 →

Olcorolimus

Investigational

Olcegepant

C₃₈H₄₇Br₂N₉O₅

Cloxazolam

C₁₇H₁₄Cl₂N₂O₂

Organizations

View all 1628 →

ANNA OLCZAK

Poland

McKesson

Amcor PLC

United Kingdom

News

View all 135 →

Unicycive Therapeutics' OLC for Hyperphosphatemia Receives 'Buy' Rating Amidst NDA Submission

Unicycive's OLC Receives FDA Acceptance for Hyperphosphatemia Treatment

Unicycive's OLC Receives FDA Acceptance for Hyperphosphatemia NDA

Page 1 of 441